GLP-1 Medications, Weight Loss, and Physical Therapy: What Providers Should Know
GLP-1 receptor agonists and related incretin-based medications, including semaglutide and tirzepatide, can produce substantial weight loss and important cardiometabolic benefits for many patients with obesity and/or type 2 diabetes.
Weight loss from GLP-1 medications usually comes mostly from fat mass, but some fat-free mass and lean mass loss can occur. Current evidence does not support the blanket claim that GLP-1 medications automatically cause frailty or clinically meaningful sarcopenia, but high-risk patients deserve thoughtful monitoring.
Physical therapists should not manage GLP-1 prescriptions, dosing, or medication side effects independently. PTs can, however, screen medication history, monitor functional changes, prescribe progressive exercise, support long-term activity habits, communicate with the prescribing provider, and refer when symptoms fall outside PT scope.
Resistance training, aerobic exercise, adequate recovery, and appropriate nutrition conversations are especially important. APTA recognizes that diet and nutrition are relevant to PT-managed conditions and that PTs may screen and provide general information while referring to dietitians or other qualified providers when care exceeds professional or personal scope.
The best conversation is not “Are GLP-1 medications good or bad?” The better conversation is: How do we help this specific patient preserve function, build strength, stay safe, and remain connected to the right healthcare team?
Exercise Prescription for Providers: Making Movement Meaningful, Measurable, and Actually Doable
Exercise prescription is more than sets, reps, and resistance. For providers, the real clinical art is matching the right dose of movement to the right person, at the right time, in a way they can understand, trust, and actually follow.
❤️ POTS, Dizziness, and a Racing Heart: Why the Conversation Matters
Postural Orthostatic Tachycardia Syndrome, better known as POTS, is a condition involving symptoms of orthostatic intolerance. That means symptoms tend to show up or worsen when someone moves into an upright position, such as sitting or standing, and often improve when lying down.
Commonly reported symptoms can include lightheadedness, dizziness, palpitations, racing heart, fatigue, exercise intolerance, nausea, headache, “brain fog,” weakness, and feeling worse in heat or after prolonged standing.
Symptoms alone do not diagnose POTS.
Many conditions can look similar, including dehydration, anemia, thyroid disease, medication effects, cardiac rhythm problems, orthostatic hypotension, vasovagal syncope, infection, anxiety, deconditioning, and other medical concerns.
For patients, this means:
You are not “making it up,” and you also deserve a careful evaluation.
For providers, this means:
We should validate symptoms, screen thoughtfully, recognize when referral is needed, and help patients build safe, progressive strategies to improve function.
🧠 “More Than Flexible”: Understanding Hypermobility, hEDS, and the Power of Listening
Hypermobility isn’t just “being flexible.” For many patients, it’s a complex, often misunderstood condition that can affect the entire body—not just joints.
Hypermobile Ehlers-Danlos syndrome (hEDS) and hypermobility spectrum disorders (HSD) can present with chronic pain, fatigue, anxiety, and multisystem symptoms. Diagnosis can take years, and patients often feel dismissed along the way.
The most effective care isn’t just clinical—it’s relational. When providers listen, validate, and collaborate, outcomes improve. Treatment works best when it’s multidisciplinary, patient-centered, and focused on long-term self-management.
Prescribing Strength, Not Just Exercise: What Clinicians Need to Know from the New 2026 ACSM Resistance Training Recommendations
Resistance training (RT) is one of the most effective and heavily studied interventions for improving strength, function, and long-term health in adults.
Most variables may not matter as much as we thought—clinicians should prioritize adherence over optimization.
Key prescriptions for clinical practice:
≥ 2 sessions/week
2–3 sets per exercise
Heavier loads (≥80% 1RM) → strength
≥ 10 sets/week/muscle group → hypertrophy
Training to failure, equipment type, timing, and complex programming?
👉 Not essential for outcomes.The clinical takeaway:
👉 It doesn’t have to be complicated - move heavy (whatever is “heavy” for you), move with purpose, and move consistently. The more you move, the more benefit you’ll have.